新兴成年人对HPV疫苗可预防疾病的优先排序及其健康教育传播启示
研究调查454名18至25岁新兴成年人,要求对7种HPV疫苗可预防疾病按重要性排序。宫颈癌、生殖器疣和口咽癌最常被列为最高优先;女性更优先女性特异性癌症,男性更优先非性别特异性癌症,部分少数族裔更优先生殖器疣。
要点
- 宫颈癌、生殖器疣和口咽癌是新兴成年人最优先关注的HPV相关疾病。
- 女性比男性更优先女性特异性癌症,男性比女性更优先非性别特异性癌症。
- 非西班牙裔亚裔和其他种族更倾向于将生殖器疣置于癌症之前。
核心结论
- 宫颈癌、生殖器疣和口咽癌是新兴成年人最常列为最高优先的HPV疫苗可预防疾病。
- 性别和种族影响疾病优先排序,疫苗推广应覆盖全部结局或按群体优先排序定制。
研究设计与样本
- 分析限于18至25岁受访者(n=454;61.9%女性;54.8%非西班牙裔白人)。
主要发现
- 宫颈癌(26.87%)、生殖器疣(19.82%)和口咽癌(17.8%)最常被列为最高优先。
- 女性比男性更优先女性特异性癌症(68% vs. 3.47%),男性比女性更优先非性别特异性癌症(44.5% vs. 13.5%;χ2=219.08;p<0.001)。
- 非西班牙裔亚裔(aOR=2.19;95%CI=1.28-3.76)和非西班牙裔其他种族(aOR=2.73;95%CI=1.32-5.68)将生殖器疣置于癌症之前的 odds 更高。
临床怎么用
- HPV疫苗推广应继续强调全部可预防结局,或针对不同群体(包括男性和少数族裔)的优先排序定制教育信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Emerging adults are at the highest risk for Human papillomavirus (HPV). HPV increases the risk of cervical, oropharyngeal, and anogenital cancers and skin lesions, leading to genital warts. However, many are unaware of the full spectrum of diseases associated with HPV. This study aimed to identify which HPV vaccine-preventable diseases are the highest priority among emerging adults and examine demographic factors related to prioritization, to inform education and communication strategies. Participants were recruited to complete a voluntary, one-time, online survey at two no-cost vaccine clinics in September and October 2024. This study is limited to respondents aged 18 to 25 (n = 454; 61.9% female; 54.8% non-Hispanic white). After being presented with a list of 7 HPV vaccine-preventable diseases, participants were asked to rank them in order of importance. Frequency analysis was conducted on the top-ranked outcome. Prioritization of outcomes, grouped by sex specificity (female, male, non-sex-specific) and latency (genital warts, cancers), was examined in relation to socio-demographic characteristics. Cervical cancer (26.87%), genital warts (19.82%), and oropharyngeal cancer (17.8%) were most often the highest priority. More females than males (68% vs. 3.47%) prioritized female-specific cancers, while more males than females (44.5% vs. 13.5%) prioritized non-sex-specific cancers (χ2 = 219.08; p < 0.001). Odds of prioritizing genital warts over cancers were higher among non-Hispanic Asian (aOR = 2.19; 95% CI = 1.28-3.76) and non-Hispanic other race (aOR = 2.73; 95% CI = 1.32-5.68). HPV vaccine promotion should continue to emphasize all outcomes or be tailored to address the outcome priorities of each group, including males and racial minorities.
引用
- Coblentz EG, Packee CR, Ky SL, et al. Prioritization of HPV vaccine preventable diseases among emerging adults - Implications for health education and communication. Vaccine. 2026. PMID: 41534482. doi:10.1016/j.vaccine.2026.128223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。